Contract

Lipoprotein Apheresis

  • NHS Wales Shared Services Partnership

F03: Contract award notice

Notice identifier: 2021/S 000-006596

Procurement identifier (OCID): ocds-h6vhtk-02a135

Published 31 March 2021, 9:16am



Section one: Contracting authority

one.1) Name and addresses

NHS Wales Shared Services Partnership

Cardiff and Vale University Local Health Board, Procurement Department, 2nd Floor, Woodlands House, Maes-y-Coed Road,

Cardiff

CF14 4TT

Email

emma.lane@wales.nhs.uk

Telephone

+44 02921836450

Country

United Kingdom

NUTS code

UKL - Wales

Internet address(es)

Main address

http://www.procurement.wales.nhs.uk

Buyer's address

http://www.sell2wales.gov.wales/search/Search_AuthProfile.aspx?ID=AA0221

one.2) Information about joint procurement

The contract is awarded by a central purchasing body

one.4) Type of the contracting authority

Body governed by public law

one.5) Main activity

Health


Section two: Object

two.1) Scope of the procurement

two.1.1) Title

Lipoprotein Apheresis

Reference number

CAV-OJEU-PROJECT43657

two.1.2) Main CPV code

  • 33696500 - Laboratory reagents

two.1.3) Type of contract

Supplies

two.1.4) Short description

The NHS Wales Shared Services Partnership, hosted by Velindre NHS Trust are acting on behalf of Cardiff and Vale University Local Health Board who are seeking to establish a unranked Framework for Lipoprotein Apheresis.

two.1.6) Information about lots

This contract is divided into lots: No

two.2) Description

two.2.2) Additional CPV code(s)

  • 33140000 - Medical consumables

two.2.3) Place of performance

NUTS codes
  • UKL22 - Cardiff and Vale of Glamorgan

two.2.4) Description of the procurement

The NHS Wales Shared Services Partnership, hosted by Velindre NHS Trust are acting on behalf of Cardiff and Vale University Local Health Board who are seeking to establish an unranked Framework for Lipoprotein Apheresis.

The Department of Medicine located at Llandough Hospital is responsible for providing the Health Board’s Lipoprotein Apheresis service. It is intended to deliver the service on a framework basis in order to include all specialist suppliers as the type of treatment essential for patients can vary due to their individual requirements.

Potential Framework Participants will be expected to supply equipment (up to 4 at any given time) and consumables to meet the Health Board’s Lipoprotein Apheresis service. They will also be required to provide maintenance, servicing and training of the machines for the duration of the Framework.

two.2.5) Award criteria

Quality criterion - Name: as per procurement docs / Weighting: 100

Price - Weighting: 0

two.2.11) Information about options

Options: No

two.2.13) Information about European Union Funds

The procurement is related to a project and/or programme financed by European Union funds: No


Section four. Procedure

four.1) Description

four.1.1) Type of procedure

Open procedure

four.1.8) Information about the Government Procurement Agreement (GPA)

The procurement is covered by the Government Procurement Agreement: Yes

four.2) Administrative information

four.2.1) Previous publication concerning this procedure

Notice number: 2019/S 241-590913


Section five. Award of contract

Contract No

CAV-OJEU-PROJECT43657

A contract/lot is awarded: No

five.1) Information on non-award

The contract/lot is not awarded

Other reasons (discontinuation of procedure)


Section six. Complementary information

six.3) Additional information

Please note additional information on this procurement:

1. The Contracting Authority reserves the right to award the contract in whole, in part or annul the tendering process and not award any contract.

2. Bidders should note that they will be required to enter into terms and conditions of contract as set out in the ITT and that save for matters of clarification or consistency the Contracting Authority will not negotiate the terms.

3. The Contracting Authority will not accept completed ITT's after the stated closing date.

4. All documents to be priced (where applicable) in sterling and all payments made in sterling.

5. All tender costs and liabilities incurred by bidders shall be the sole responsibility of the bidders.

6. Prospective suppliers should note that NHS Shared Services Partnership - Procurement Services is acting on behalf of Cardiff and Vale University Local Health Board.

7. Bidders wishing to participate should visit the Bravo e-tenderwales portal and access the itt_79366.

(WA Ref:109475)

six.4) Procedures for review

six.4.1) Review body

NHS Wales Shared Services Partnership

Cardiff

Country

United Kingdom

six.4.3) Review procedure

Precise information on deadline(s) for review procedures

NHS Wales Shared Services Partnership on behalf of Cardiff and Vale University Local Health Board will allow a minimum 10 calendar day standstill period between notifying the award decision and awarding the contract.

Unsuccessful tenderers and applicants are entitled to receive reasons for the decision, including the characteristics and relative advantages of the winning bid and the reasons why the tenderer/applicant was unsuccessful. Should additional information be required it should be requested of the addressee in section I.1. Aggrieved parties who have been harmed or are at risk of harm by breach of the procurement rules have the right to take action in the High Court (England and Wales). Any such action is subject to strict time limits in accordance with the Public Contracts (Amendments) Regulations 2015.